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Abstract.  Subtractive hybridization, selecting for 
mRNAs expressed in normal human mammary epithe- 
lial cells (NMECs) but not in mammary tumor cell 
lines (TMECs), led to the cloning of the human gap 
junction gene connexin 26 (Cx26),  identified by its 
sequence similarity to the rat gene. Two Cx26 tran- 
scripts derived from a  single gene are expressed in 
NMECs but neither is expressed in a series of TMECs. 
Northern analysis using rat Cx probes showed that 
Cx43 mRNA is also expressed in the normal cells, but 
not in the tumor lines examined. Connexin genes 
Cx31.1, Cx32, Cx33, Cx37, and Cx40 are not expressed 
in either normal cells or the tumor lines examined. In 
cell-cell communication studies, the normal cells trans- 
ferred Lucifer yellow, while tumor cells failed to show 
dye transfer. Both Cx26 and Cx43 proteins were im- 
munolocalized to membrane sites in normal cells but 
were not found in tumor cells. 
Further analysis demonstrated that Cx26 is a cell- 
cycle regulated gene expressed at a  moderate level 
during G1 and S,  and strongly up-regulated in late 
S and G2, as shown with lovastatin-synchronized 
NMECs.  Cx43,  on the contrary is constitutively ex- 
pressed at a uniform low level throughout the cell cy- 
cle. Treatment of normal and tumor cells with a  series 
of drugs:  5dB-cAMP, retinoic acid, okadaic acid, es- 
tradiol, or TGFb had no connexin-inducing effect in tu- 
mor cells. However, PMA induced re-expression of 
the two Cx26 transcripts but not of Cx43 in several 
TMECs.  Thus Cx26 and Cx43 are both downregulated 
in tumor cells but respond differentially to some sig- 
nals.  Modulation of gap-junctional activity by drug 
therapy may have useful clinical applications in 
cancer. 
C 
ANCER develops in multiple genetic steps, at many of 
which ceils lose opportunities for tumor suppression 
(16, 24, 30).  One such step can be the loss of gap- 
junctional communication. A role for cell-cell communica- 
tion in tumor suppression was first proposed in the 1960's by 
Stoker (27)  and by Loewenstein (15).  Stoker showed that 
polyoma virus-transformed BHK fibroblasts could be growth 
arrested by cocultivation with untransformed BHK cells; and 
Loewenstein demonstrated electrical coupling between ad- 
jacent normal rat liver ceils that was  lost in  four rodent 
hepatomas. 
Subsequent studies by many investigators have established 
a correlation between gap-junctional intercellular communi- 
cation  (GJIC) ~ and growth control  or  suppression  of the 
transformed phenotype using rodent fibroblasts in culture 
(for reviews see 18, 19, 29, 32). In human cancer, examples 
of tumor cells with and without communicating ability have 
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been described, but reports of the loss of this property are 
much more frequent than its retention. In early studies of 
breast  cancer,  cell  lines  were  examined  for  their  com- 
municating ability using 3H-uridine  transfer (9,  27).  Most 
tumor cells showed no homologous transfer between cells of 
the same cell line. On the contrary, normal breast epithelial 
cells showed strong homologous transfer. These findings ob- 
tained before the  connexin genes and proteins  had been 
identified foreshadowed the results reported here. 
In this laboratory a selection system was established to re- 
cover tumor suppressor genes, using subtractive hybridiza- 
tion to isolate mRNAs expressed in normal but not in closely 
related human mammary carcinoma cells (13, 14, 24).  An 
important assumption underlying this approach is that nor- 
mal tumor suppressor genes are preferentially or uniquely 
expressed in normal cells, and lost in tumor cells, as exem- 
plified by retinoblastoma, normal p53,  and Wilms' tumor 
genes (16, 24, 30). 
Using subtractive hybridization (6,  13,  14), we have iso- 
lated the gene Cx26 encoding a  gap-junctional structural 
protein, connexin 26, identified by its sequence similarity to 
rat Cx26 (33). It is shown here that Cx26 is expressed in nor- 
mal human mammary epithelial cells but not in a series of 
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the subtraction (13). Consistent with the Northern hybridiza- 
tion data, the tumor cells showed no junctional communicat- 
ing ability as assayed by Lucifer yellow dye transfer whereas 
the normal cells were active in GJIC. 
The evidence from this study that connexins are transcrip- 
tionally downregulated in tumor cells compared with their 
normal mammary epithelial counterparts focuses interest on 
the  regulatory  mechanisms  involved.  To  understand  the 
regulation of connexin gene expression is central to investi- 
gations of gap-junctional functions in development and in 
disease.  Preliminary studies presented here of messenger 
stability, cell cycle regulation, and the differential responses 
of Cx26 and Cx43 to drug treatments open new avenues for 
further research. 
Materials and Methods 
Cells and Cell Cultures 
Normal human mammary epithelial cells strains (70N, 76N, 81N) were de- 
rived from reduction mammoplasty tissues (2).  Human breast tumor cell 
lines  were  obtained  from  ATCC  BT549  (HTB123),  MDA-MB-231 
(HTB26),  SKBR3 (HTB30),  T47D  (HTB133),  ZR75-1  (CRL1500).  The 
ATCC numbers are indicated parenthetically. The MCF7 line was obtained 
from the Michigan Cancer Foundation (Detroit,  MI).  21T series (21PT, 
21NT,  21MT2,  and 21MT1) were established in this laboratory (4).  All 
manumu-y epithelial cells were maintained in DFCI-1 complete medium (4) 
or in c~-MEM supplemented with insulin, hydrocortisone, EGF, and 10% 
FCS (Hyclone Laboratories Inc., Logan, UT) (3). All cells were cultured 
at 37~  in a humidified atmosphere with 6.5% COz/93.5%  air. 
Exponentially growing cells were treated in separate experiments with 
the  following drugs:  dBc-cAMP,  1  mM  in  double distilled (dd)  HeO; 
PMA, 100 ng/mi in DMSO; ail-trans retinoic acid, 1/~M in absolute etha- 
nol (experiment performed in the dark);  Actinomycin D, 5/~g/ml in dd 
H20; cycloheximide, 10/Lg/mi in dd H20;/3-estradiol, 2 nM in absolute 
ethanol (all the above from Sigma Chemical Co., St. Louis, MO); TGF~, 
1 ng/mi in dd H20 (from Collaborative Research Inc., Bedford, MA); and 
okadaic acid (Tanaka Biochemical Co., Japan), 5 ng/mi in dimethyl forma- 
mide. Controls were treated with solvent alone for the times indicated in 
the text. Total  RNA was extracted as indicated. 
DNA and RNA Analysis 
High molecular weight genomic DNA was isolated from manunary epithe- 
lial cells as previously described (14). DNA (10 ~g) was digested with re- 
striction enzymes (BamHI or BglI), and then subjected to Southern analysis 
(14). Total RNA was extracted from exponentially growing cells. For North- 
ern  analysis,  total  RNA  (20  /tg/lane)  was  denatured,  electrophoresed 
through  a  1.0-1.2%  agarose-formaidehyde gels,  transferred  to  nylon- 
membrane (Zeta-probe, BioRad, Richmond, CA), and hybridized as previ- 
ously described (14). All probes were labeled to a specific activity of 109 
cpm//~g DNA. Poly(A)  +  RNA was purified by oligo(dT) cellulose chroma- 
tography, eDNA was synthesized with the Moloney murine leukemia virus 
reverse transcriptase (Gibco BRL,  Gaithersburg,  MD) according to the 
manufacturer's instructions (14). The probe 36B4 was used as a loading con- 
trol (11). 
Isolation of Human Cx26 (Cx26) cDNA 
Human Cx26 eDNA was isolated by subtractive hybridization, using eDNA 
from normal mammary epithelial cells (NMEC),  strain 76N,  and total 
mRNA  from the  tumor-derived mammary  epithelial  cell  line,  21MT2 
(TMEC) (13, 14). To isolate sequences which are only expressed in the nor- 
real cells, a  subtracted cDNA probe from 76N cells recovered after two 
rounds of subtraction was labeled by random priming, and used to screen 
a  76N  eDNA library made in ~,ZapII  (Stratngene Inc.,  La Jolla,  CA). 
'xt0,000 recombinant phage (2-4  x  103 per 150-mm dish) were trans- 
ferred in duplicate to nitroceUulose filters (Schleicher and Schuell Inc., 
Keene, NH), and the DNA on filters was immobilized by baking at 80~ 
for 1 h. The filters were prehybridized for 12 h or more at 42~  in 5￿  SSC, 
5x  Denhart's solution,  1%  SDS,  10 tzg/mi of poly(A)  +,  and  100/zg/mi 
salmon sperm DNA. One set of filters was hybridized with the 32p ran- 
dom labeled subtracted probe and the other with a TMEC specific eDNA 
probe. After 24 h at 42~  the filters were washed sequentially at low and 
high stringency and after radiography plaques that showed positive hybrid- 
ization only with subtracted probe, they were purified and subjected to sec- 
ondary and tertiary screening. Duplicate filters were hybridized with a 76N 
eDNA probe and with a TMEC eDNA probe. 50 clones were recovered, 
and further analyzed to confirm  the differential expression  pattern on North- 
erns.  Inserts from positive recombinants were amplified by polymerase 
chain reaction (PCR)  directly from phage lysates using T3  and T7  se- 
quences as primers. Differentially hybridizing clones were transferred into 
plasmids using the phagemid excision protocol (Stratagene Inc.). The full- 
length coding sequence of  human Cx26 was isolated by rescreening the 76N 
library using a partial eDNA insert. 
Sequence A nalysis 
Progressive unidirectional deletions of the human Cx26 full-length eDNA 
clone were generated using exonuclease HI (Erase-A-Base System; Promega 
Corp., Madison, WI). The original eDNA clone and the deleted derivatives 
were sequenced by the dideoxy termination sequencing method (25) with 
T7 DNA polymerase (Pharmacia Fine Chemicals, Piscataway,  NJ) or Se- 
quenase (version 2.0; US Biochemical Co., Cleveland, OH). The sequence 
was identified as closely related to rat Cx26 in C-enBank. 
Immunofluorescence 
Confluent cells grown on coverslips were treated as desc,  ibed (18).  Rabbit 
polyclonal anti-sera against rat Cx26 (33) and rat Cx43 (20) were used for 
immunostaining. 
Cell Communication Assays 
Intercellular dye transfer was studied by iontophoresing the fluorescent dye 
Lucifer yellow CH (Sigma Chemical Co.) into cells and following the dye 
movement into surrounding cells with epiilhimination fluorescence optics. 
The specimen stage was warmed to 37~  and a stream of 95% (h/5% CO2 
was directed over the specimen throughout the experiment. High resistance 
microelentrodes (80-120 Mohm) were filled from tip to shoulder with 4% 
Lucifer yellow in water, then back filled with 3 M LiCI. After cell penetra- 
tion, dye was iontophoresed with 0.5 s, 5 na pulses at 1 Hz.  15 separate 
cells of each type were injected. Injections were performed for 6 rain and 
then immediately photographed. 
Scrape loading was performed  for rough measurement  of  cell communica- 
tion according to a procedure development by E1-FOuly et ai. (8). The cells 
were grown to confluence in 35-ram plates, washed three times with serum- 
free medium, incubated for 1 min with 40/~1 of 1% Lucifer yellow-CH and 
1% Rhodamine dextran (Molecular Probes, Inc., Eugene, OR). The cells 
were scratched at 2-3-ram intervals, using a fine needle, washed three times 
with  serum  free  medium,  observed,  and  photographed  on  a  Zeiss- 
Axioscope using the appropriate filters (Carl Zeiss Inc., Thornwood, NY). 
Cell Synchronization  of NMECs 
Cells were plated in 24-well dishes and in  150-mm plates at 6.7  x  103 
cells/cm  2. For all conditions the volume of media used was 1.5 ml/well of 
Zywell dishes and 20 ml/150 mm plates. 36-48 h after plating, cells were 
washed and incubated with fresh medium containing lovastatin (15/zM) for 
24 h.  Under these conditions, cells are arrested in G1 as determined by 
[3HI thymidine incorporation and positive staining of cells with Ki-67 anti- 
body (11). At time zero cells were re-fed with fresh medium containing 
mevaionic acid (2.0 raM) and harvested at the indicated times (0-33 h); 
DNA synthesis and cell density were measured. 
Results 
Isolation of a cDNA Clone Encoding the Human Gap 
Junction Protein Cx26 by Subtractive Hybridization 
Subtractive hybridization was carried out to select for genes 
expressed in NMECs (76N) but not in mammary carcinoma 
cells (21MT-2). Briefly, single stranded eDNA from the nor- 
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GATTTAATCCTATGACAAACTAAGTT 
GGTTCTGTCTTCACCTGTTTTGGTGAGGTTGTGTAAGAGTTGGTGTTTGCTCAGGAAGAGATTTAAGCATGCTTGCTTACCCAGACT 
CAGAGAAGTCTCCCTGTTCTGTCCTAGCTAGTGATTCCTGTGTTGTGTGCATTCGTCTTTTCCAGAGCAAACCGCCCAGAGTAGAAG 
ATG  GAT  TGG  GGC  ACG  CTG  CAG  ACG  ATC  CTG  GGG  GGT  GTG  AAC  AAA  CAC  TCC  ACC  AGC  ATT  GGA  AAG 
M  D  W  G  T  L  Q  T  I  L  G  G  V  N  K  H  S  T  S  I  G  K 
S 
ATC  TGG  CTC  ACC  GTC  CTC  TTC  ATT  TTT  CGC  ATT  ATG  ATC  CTC  GTT  GTG  GCT  GCA  AAG  GAG  GTG  TGG 
I  W  L  T  V  L  F  I  F  R  I  M  I  L  V  V  A  A  K  E  V  W 
GGA  GAT  GAG  CAG  GCC  GAC  TTT  GTC  TGC  AAC  ACC  CTG  CAG  CCA  GGC  TGC  AAG  AAC  GTG  TGC  TAC  GAT 
G  D  E  Q  A  D  F  V  C  N  T  L  Q  P  G  C  K  N  V  C  Y  D 
CAC  TAC  TTC  CCC  ATC  TCC  CAC  ATC  CGG  CTA  TGG  GCC  CTG  CAG  CTG  ATC  TTC  GTG  TCC  AGC  CCA  GCG 
H  Y  F  P  I  S  H  I  R  L  W  A  L  Q  L  I  F  V  S  S  P  A 
M  T 
CTC  CTA  GTG  GCC  ATG  CAC  GTG  GCC  TAC  CGG  AGA  CAT  GAG  AAG  AAG  AGG  AAG  TTC  ATC  AAG  GGG  GAG 
L  L  V  A  M  H  V  A  Y  R  R  H  E  K  K  R  K  F  I  K  G  E 
M 
ATA  AAG  AGT  GAA  TTT  AAG  GAC  ATC  GAG  GAG  ATC  AAA  ACC  CAG  AAG  GTC  CGC  ATC  GAA  GGC  TCC  CTG 
I  K  S  E  F  K  D  I  E  E  I  K  T  Q  K  V  R  I  E  G  S  L 
N 
TGG  TGG  ACC  TAC  ACA  AGC  AGC  ATC  TTC  TTC  CGG  GTC  ATC  TTC  GAA  GCC  GCC  TTC  ATG  TAC  GTC  TTC 
W  W  T  Y  T  S  S  I  F  F  R  V  I  F  E  A  A  F  M  Y  V  F 
T  V 
TAT  GTC  ATG  TAC  GAC  GGC  TTC  TCC  ATG  CAG  CGG  CTG  GTG  AAG  TGC  AAC  GCC  TGG  CCT  TGT  CCC  AAC 
Y  V  M  Y  D  G  F  S  M  Q  R  L  V  K  C  N  A  W  P  C  P  N 
I  N  F 
ACT  GTG  GAC  TGC  TTT  GTG  TCC  CGG  CCC  ACG  GAG  AAG  ACT  GTC  TTC  ACA  GTG  TTC  ATG  ATT  GCA  GTG 
T  V  D  C  F  V  S  R  P  T  E  K  T  V  F  T  V  F  M  I  A  V 
I  S 
TCT  GGA  ATT  TGC  ATC  CTG  CTG  AAT  GTC  ACT  GAA  TTG  TGT  TAT  TTG  CTA  ATT  AGA  TAT  TGT  TCT  GGG 
S  G  I  C  I  L  L  N  V  T  E  L  C  Y  L  L  I  R  Y  C  S  G 
I  F 
AAG  TCA  AAA  AAG  CCA  GTT  TAA 
K  S  K  K  P  V  - 
R 
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CGCATTGCCCAGTTGTTAGATTAAGAAATAGACAGCATGAGAGGGATGAGGCAACCCGTGCTCAGCTGTCAAGGCTCAGTCGCCAGC  768 
ATTTCCCAACACAAAGATTCTGACCTTAAATGCAACCATTTGAAAC•CCTGTAGGCCTCAGGTGAAACTCCAGATGCCACAATGAGC  855 
TCTGCTCCCCTAAAGCCTCAAAACAAAGGCCTAATTCTATGCCTGTCTTAATTTTCTTTCACTTAAGTTAGTTCCACTGAGACCCCA  942 
GGCTGTTAGGGGTTATTGGTGTAAGGTACTTTCATATTTTAAACAGAGGATAT•GGCATTTGTTT•TTTCTCTGAGGACAAGAGAAA  1029 
AAAGCCAGGTTCCACAGAGGACACAGAGAAGGTTTGGGTGTCCTCCTGGGGTTCTTTTTGCCAACTTTCCCCACGTTAAAGGTGAAC  1116 
ATTGGTTCTTTCATTTGCTTTGGAAGTTTTAATCTCTAACAGTGGACAAAGTTACCAGTGCCTTAAACTCTGTTACACTTTTTGGAA  1203 
GTGAAAACTTTGTAGTATGATAGGTTATTTTGATGTAAAGATGTTCTGGATACCATTATATGTTCCCCCTGTTTCAGAGGCTCAGAT  1290 
TGTAATATGTAAATGGTATGTCATTCGCTACTATGATTTAATTTGAAATATGGTCTTTTGGTTATGAATACTTTGCAGCACAGCTGA  1377 
GAGAGGCTGTCTGTTGTATTCATTGTGGTCATAGCACCTAACAACATTGTAGCCTCAATCGAGTGAGACAGACTAGAAGTTCCTAGT  1464 
TGGCTTATGATAGCAAATGGCCTCATGTCAAATATTAGATGTAATTTTGTGTAAGAAATACAGACTGGATGTACCACCAACTACTAC  ]551 
CTGTAATGACAGGCCTGTCCAACACATCTCCCTTTTCCATGCTGTGGTAGC•AGCATCGGAAAGAACGCTGATTTAAAGAGGTGAG•  1638 
TTGGGAATTTTATTGACACAGTACCATTTAATGGGGAGACAAAAATGGGGGCCAGGGGAGGGAGAAGTTTCTGTCGTTAAAAACGAG  1725 
TTTGGAAAGACTGGACTCTAAATTCTGTTGATTAAAGATGAGCTTTGTCTACCTTCAAAAGTTTGTTTGCTTACCCCCTTCAGCCTC  1812 
•AATTTTTTAAGTGAAAATATAACTAATAA•ATGTGAAAAGAATAGAAGCTAAGGTTTAGATAAATATTGAGCAGATCTATAGGAAG  1899 
ATTGAACCTGAATATTGCCATTATGCTTGACATGGTTTCCAAAAAATGGTACTCCACATACTTCAGTGAGGGTAAGTATTTTCCTGT  1986 
TGTCAAGAATAGCATTGTAAAAGCATTTTGTAATAATAAAGAATAGCTTTAATGATATGCTTGTAACTAAAATAATTTTGTAATGTA  2073 
TCAAATACATTTAAAACATTAAAATATAATCTCTATAAT  2112 
Figure L Nucleotide and de- 
duced amino acid sequence for 
human  Cx26  eDNA.  Num- 
bers to the left and right of the 
sequence  show the positions 
of amino acids  and  nucleo- 
tides, respectively.  A consen- 
sus  splice  acceptor signal  is 
underlined  at  23  nucleotides 
upstream from the ATP trans- 
lation start site. In the 3' non- 
coding region polyadenylation 
signal  sequences  AATAAA 
and ATTAAA are underlined 
and the putative instability se- 
quence ATTTA is also under- 
lined.  The amino acid differ- 
ences in the rat sequence  are 
shown below the human  se- 
quence.  These sequence  data 
are  available  from  EMBL/ 
G-enBank/DDBJ under acces- 
sion number M86849. 
mal cells (76N) was hybridized with a large excess of tumor 
mRNA and the nonhybridizing pool of 76N cDNAs was re- 
covered as the subtracted probe.  Further screening of this 
pool by differential hybridization yielded  15 clones that hy- 
bridized uniquely  with  the  subtracted  76N  library.  These 
clones were partially  sequenced,  and one of them (called 
clone  1-3)  was found to have high  homology with the rat 
Cx26  sequence  reported  in  GENBANK  (29).  Using  this 
clone as probe,  '~ 60,000  plaques  of the total 76N  library 
were screened,  and among the clones recovered, one con- 
tained the full-length  Cx26 eDNA. 
Sequence Analysis of  Human Connexin 26 
The full-length clone was sequenced on both strands. Com- 
parison of its peptide sequence to the GENBANK data base 
revealed close homology to rat gap junction protein connexin 
26 (33).  The nucleotide and deduced amino acid sequence 
of the coding region is shown in Fig.  1.  This cDNA clone 
has a single long open reading frame that extends to a stop 
codon at base  881,  and encodes a putative protein of 226 
amino  acid  residues  with  a  predicted  molecular  mass  of 
~26  kD. 
Preceding the initiator ATG, 23 nucleotides upstream from 
ATG,  is a consensus splice acceptor signal (TTTTCCAG). 
This signal sequence is not present in the 5' region of the rat 
Cx26 sequence (33) which does not produce two transcripts. 
The 3' untranslated region contains a possible polyadenyla- 
tion  signal  sequence  AATAAA  positioned  87  nucleotide 
upstream from the poly(A) + tail.  A  putative instability  se- 
quence,  ATTTA,  which may be involved in mRNA  insta- 
bility,  is present at nucleotide positions  1326,  1623,  1664, 
and 2082  (26). 
Sequence Comparison of  Human Cx26 to Rat Cx26 
The  overall nucleotide homology between human and rat 
Cx26 is 86.2%  within the open reading frame.  The amino 
acid sequence deduced from human is 92.5 % identical to rat 
Cx26. Of the 226 amino acids, there are only 15-amino acid 
differences between the two species. These substitutions are 
indicated in Fig.  1. Structural characteristics are conserved. 
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(,4) Northern blot analysis. P32-1abeled  cDNAs from human Cx26, 
rat Cx43, and 36IM (loading control) were hybridized with total 
RNAs extracted from exponentially growing cells: NMEC,  76N 
and 81N; TMEC, 21PT, 21NT, 21MT2, MCFT,, B'P349, and SKBR3. 
Transcript sizes and position of 18S RNA are indicated. (B). South- 
ern analysis of human Cx26 genomic DNA. Genomie DNA was 
isolated, digested with restriction enzymes (BamHI in upper line 
and BglI in lower line), separated by 0.8 % agarose gel electropho- 
resis, and transferred to a nylon membrane and hybridized with hu- 
man Cx26 eDNA. 7ON, 76N, and 81N, NMEC; 18-2P-1, HPV im- 
mortalized mammary epithelial ceils; 21NT, MCF7, ZR754, T47D, 
HBLIO0, MDA-MB-436, and MDA-MB-468, TMEC. Position and 
size of )~ HindIII fragments are shown on the left. 
In addition, the potential consensus sites for kinases are also 
conserved in  human  Cx26  peptides  (Tyr  97  and  Tyr  217  for 
tyrosine  kinase,  Ser  219  for  Ca2+-dependent  kinase)  (33). 
However, the 5' and  3' untranslated  regions  show  no sig- 
nificant similarity between human and rat. 
Expression of Cx26 and Cx43 in Human Normal and 
Tumor Mammary Epithelial Cells 
Cx26 eDNA was examined for mRNA expression in a series 
of NMEC and TMEC. Northern blot analysis revealed the 
expression of two major mRNA transcripts, 2.4 and 2.8 kb, 
in the NMEC but not in the TMEC series (Fig. 2 A). Tran- 
script  sizes  were  determined  by  reference to  ribosomal 
RNAs  as  seen by  ethidium  bromide  staining.  The  weak 
lowest band is a distortion of the gel by the 18S ribosomal 
RNA.  A  weak  upper  band  may  represent  incompletely 
processed mRNA. It is not seen consistently in other gels. 
The two major bands were abundantly expressed in normal 
cells 76N and 81N (as well as 70N and 94N not shown), and 
very weakly in primary TMECs 21NT and 21PT. In contrast, 
no expression was seen in any of the tested TMECs shown 
in Fig.  2  A  (i.e.,  21  MT-2,  MCF7,  B1549,  SKBR3 or in 
21MT-1, BT-20, MDA-MB-157,  -231, -435, -436, -468, T47D, 
or ZR-75-1  [not shown]). 
The possibility that a different gap junction protein might 
be expressed in human breast ceils was examined by North- 
ern blot analysis using the rat eDNA probes for Cx26 (33), 
Cx32 (22), and Cx43 (5, 22) (Fig. 2 A). Cx43 was expressed 
only in the normal ceils in parallel with Cx26. Cx32 was not 
expressed by any of these normal or tumor cells (data not 
shown). After the cloning of new connexins (10, 23, 31), we 
examined the expression of Cx31.1,  Cx33, Cx37, Cx40, and 
Cx46 in several normal and tumor lines but no expression 
was  seen  in  a  long  exposure  at  moderate  stringency  of 
DNA-RNA hybridization. 
To examine the possibility of  a deletion or gross rearrange- 
ment in the human Cx26 gene of the tumor cells, genomic 
DNA from normal and tumor cells was digested with restric- 
tion enzymes (BamHI, BglI) and subjected to Southern blot 
analysis using a full-length human Cx26 cDNA probe (Fig. 
2  B).  After hybridization,  a  single band  (~5.7  kb  from 
BamHI, ~4.8 kb from BglI) was detected in all digests, indi- 
cating that the Cx26 gene is present in both normal and tu- 
mor  cells without detectable gross  rearrangement.  Thus, 
loss of connexin rnRNA in tumor cells seems to result pri- 
marily from transcriptional regulation or mRNA instability. 
The presence of a single band in Southern blots suggests that 
the two mRNA transcripts are derived from the same gene, 
and may result from alternate splicing, leading to insertion 
or deletion of additional sequences or to differences in poly- 
adenylation. Studies of mRNA stability in normal cells with 
actinomycin D and cycloheximide, presented below, indicate 
that the upper transcript is quite stable, whereas the lower 
transcript decreases within 30 min. 
Immunolocalization of Gap Junction Proteins Cx26 
and Cx43 
The intracellular localization of the gap junction proteins 
was  examined by  indirect immunofluorescence using  an- 
tipeptide antibodies specific for either Cx26 (33) or Cx43 
(12).  The NMEC  line 76N,  displayed regions of punctate 
fluorescence as well as diffuse intracellular staining for both 
Cx26 and Cx43 (Fig. 3, D and H, respectively). The labeling 
patterns for Cx26 and Cx43 were similar.  Comparison of 
phase-contrast and fluorescence images  suggested that the 
punctate labeling often corresponded to regions of cell-cell 
contact (Cx26, Fig. 3, C and D; Cx43, Fig. 3, G and H). Pre- 
immune controls did not display punctate labeling but indi- 
cated that some of the diffuse intracellular labeling may be 
nonspecific (Fig. 3, B and F). No specific labeling for either 
connexin was observed in 21MT2 cells (data not shown), 
consistent with the lack of connexin mRNA expression in 
this tumor line (Fig. 2 A). 
Junctional Communication of NMECs and TMECs 
Dye transfer was used to detect the presence of functional 
gap junctions. A series of micro-iontophoretic injections of 
Lucifer yellow were performed in the normal cell line 81N 
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tion  of gap-junction  proteins 
(Cx26, Cx43) in human mam- 
mary epithelial ceils (76N) by 
indirect immunofluorescence. 
Cells  were  fixed  in  parafor- 
maldehyde  and  reacted  with 
anti-Cx26 or Cx43. (A and B) 
76N cells incubated with pre- 
immune  serum;  (C  and  D) 
76N cells incubated with anti- 
Cx26  antibody;  (E  and  F) 
76N ceils incubated with pre- 
immune  serum;  (G and  H) 
anti-Cx43  antibody  staining. 
A,  C,  E,  and  G  are  phase- 
contrast  micrographs  of 76N 
cells,  and B, D, F,, and H are 
indirect  immunofluorescence 
images. Cx26  and Cx43 spe- 
cific  staining  was  found  at 
cell-cell  interface  junction 
areas in normal human mam- 
mary  epithelial  cells.  Bar, 
10/~m. 
(Fig.  4, A  and B) and the metastatic tumor line 21  MT-2 
(Fig. 4, C and D). Injected cells are marked with an asterisk. 
In the normal cells, dye could always be detected in at least 
third order neighboring ceils. The tumor line was never ob- 
served  to  pass  dye.  Thus,  the  presence  of Cx26  and  43 
mRNAs correlated well with the presence of gap junctional 
communication. 
Stability of Cx26 and Cx43 mRNAs after Actinomycin 
D and Cycloheximide Treatment 
To look for differences in mRNA stability of the two Cx26 
transcripts and the Cx43 transcript, 76N cells were exposed 
to actinomycin D to block further transcription. Samples of 
total RNA, prepared at various times (0-12 h) after addition 
of the  drug,  were  analyzed on  a  Northern  blot  (Fig.  5). 
Differential regulation of rnRNA levels was observed for the 
two Cx26 transcripts. Although the 2.8-kb upper transcript 
was slightly decreased upon actinomycin D  treatment, the 
level of lower transcript (2.4 kb) was rapidly reduced with 
a half-life of < 30 rain. Thus, the upper band showed persis- 
tence of preexisting message. Rehybridizing of the blots with 
Cx43 cDNA showed that Cx43 mRNA remained stable over 
the  12-h period (data not shown). 
Treatment of 76N cells with cycloheximide for 1-24 h also 
revealed  differences  in  regulation  of the  two  Cx26  tran- 
scripts.  The upper band was stable for  12 h  and then de- 
creased, whereas the lower band decreased during the 12-h 
period and was gone at 24 h. No detectable effect of cyclo- 
heximide  could  be  seen  on  Cx43  mRNA  over the  12-h 
period. These results demonstrate relative stability of the up- 
per Cx26 and Cx43 transcripts in contrast to the lower Cx26 
transcript  in  NMECs.  In  TMECs,  however,  neither  ac- 
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thelia but not manunary tumor lines produce 
functional gap junctions that allow dye transfer. 
(A and B) Phase-contrast and corresponding 
fluorescence micrographs of 8  IN normal mam- 
mary epithelial  cells. The injected cell is marked 
with an asterisk. Rapid and extensive transfer 
of dye is observed. (C and D) Phase-contrast 
and corresponding fluorescence micrograph of 
21 MT-2 tumor ceils. Three cells were sepa- 
rately injected. No transfer of dye is detected 
under these conditions. 
tinomycin D nor cycloheximide induced expression of either 
Cx26 or Cx43 mRNAs  (data not shown). 
Cell Cycle Expression of Cx26 and Cx43 in 
Synchronized Cells 
To assess the relative periodicity of connexin gene expres- 
sion during the cell cycle, NMECs were synchronized in G~ 
by lovastatin (15 #M/24 h), released from lovastatin-induced 
arrest by the addition of 2 mM mevalonate (11). Ceils were 
sampled at 3-h intervals over the next 33 h  and Cx26 and 
Cx43 transcript levels were analyzed by Northern blot analy- 
sis. (Fig. 6 A). Progression of the cells through the cell cycle 
was monitored by [3H]thymidine incorporation and by the 
level of  histone 1-14  mRNA in Northern blot analysis. The ap- 
pearance of histone H4 message coincided with the  18-h 
Figure 5. Effect of actinomycin D and cycloheximide on transcrip- 
tion of  Cx26 in 76N. Ceils were treated in the presence and absence 
of actinomycin D (5 #g/ml) for 12 h or eycloheximide (10 #g/ml) 
for 24 h. Total RNA was prepared from cells sampled at times indi- 
cated, and 20 #g samples were analyzed by Northern blot hybrid- 
ization with P32-1abeled human Cx26 and 36B4 (loading control) 
probes. 
peak of DNA synthesis as measured by [3H]thymidine in- 
corporation (Fig. 6 B). 
In these cells the cycle time was 27 h and the G1/S bound- 
ary was  "~12 h  after addition of mevalonate, as  shown by 
[3H]thymidine  incorporation.  Both  Cx26  transcripts  in- 
creased about twofold at 6 h, and remained relatively con- 
stant until 21 h when another 2.5-fold increase in the upper 
transcript and 3.5-fold increase in the lower transcript oc- 
curred.  What  is  most  significant  is  that  both  transcripts 
showed a  sharp rise in late S  phase.  In contrast to Cx26 
mRNA, Cx43 expression during the cell cycle was relatively 
invariant (Fig. 6 A). Thus Cx26 and Cx43 mRNAs are differ- 
ently regulated in the normal mammary epithelial cell cycle. 
Phorbol Ester (PMA) Stimulation of Cx26 mRNA 
Expression in Human Mammary Tumor Cells 
The possibility was examined that expression of Cx26 or 
Cx43 might be induced in tumor cells by drugs that affect sig- 
nal transduction pathways. Accordingly, normal and tumor 
cells were treated with PMA, retinoic acid, dB-cAMP, for- 
skolin, okadaic acid, or TGF~. Of these drugs, only PMA 
was effective in inducing Cx26 mRNA expression in tumor 
cells. As shown in Fig. 7 A, there was induction of  both Cx26 
transcripts in the treated cells. The level of both transcripts 
increased at 3 h and reached its peak at 6 h. In contrast, nei- 
ther PMA  nor any of the other treatments induced Cx43 
mRNA expression in these tumor cells. We also examined 
the effect of PMA in several TMEC lines over a treatment 
period of 3-12 h.  Exposure of tumor cells (21PT, ZR75-1, 
and MDA-MB-231) to PMA induced the expression of Cx26 
mRNA (Fig. 7 B), but not the expression of Cx43 (data not 
shown). 
The Journal of Cell Biology,  Volume 118, 1992  1218 Figure 7. Effect of PMA on expression of Cx26 and Cx43 mRNAs 
in normal and tumor mammary epithelial cells. (,4)  81N and 21MT2 
cells were treated with 100 ng/ml of PMA for the indicated times, 
and total RNA was isolated and analyzed by Northern hybridization 
(20 t~ghane  total RNA). The same blot was hybridized successively 
with 32P-labeled Cx26, Cx43, and ~/-actin probes. (B) Expression 
of Cx26 mRNA in PMA-treated (100 ng/ml) tumor cells. At each 
indicated time, RNA was extracted, and analyzed by Northern blot 
hybridization (20/~g total RNA/lane). The same blot was hybri- 
dized with 36B4 as a loading control. 
Figure 6.  Cx26 and Cx43 mRNAs during cell cycle progression. 
(A) Analysis of  Cx26 and Cx43 transcripts in normal mammary ep- 
ithelial cells (70N) undergoing synchronous cell cycle progression 
after release  in early G1  from  lovastatin-induced arrest.  Total 
RNA was extracted at indicated times (0--33 h), and 20 #g/lane was 
separated on 1% formaldehyde-agarose  gels and analyzed by North- 
em blots using Cx26, Cx43, historic 1-14, and 36B4 (loading control) 
as probes. (B) Rate of DNA synthesis measured by PH]thymidine 
incorporation. Relative rates were estimated by measuring the in- 
corporation  of [3H]thymidine during  cell progression of a  syn- 
chronous population. 
The effect of PMA on cormexin gene expression was also 
examined in NMECs (81N). Unlike tumor cells, the expres- 
sion of Cx26 mRNA was decreased by PMA at 6 h whereas 
longer  exposures  resulted  in  subsequent  upregulation  to 
pretreatment levels by  24  h.  However, the  expression of 
Cx43 mRNA in the same experiment was gradually dimin- 
ished to barely detectable levels by 24 h (data not shown). 
To see whether Cx26 mRNA stimulation in PMA-treated 
tumor cells leads to protein synthesis, immunofluorescence 
staining  with  anti-Cx26  antibody and  scrape-loading  dye 
transfer experiments were performed at various times after 
PMA treatment, using several TMEC lines. Cx26 proteins 
were not detected at cell-cell junctional areas nor was junc- 
tional  communication  detected  between  cells  (data  not 
shown).  Neither method was sensitive enough to detect a 
very weak signal. 
Discussion 
This paper has shown that normal human mammary epithe- 
lial cells express two connexin genes, Cx26 and Cx43. Nei- 
ther transcript is found in mammary tumor cell lines,  al- 
though a trace is present in two lines of recent origin from 
a primary tumor. The normal ceils express both genes at the 
mRNA and protein levels, and show abundant gap junctional 
communication as judged by dye transfer using Lucifer yel- 
low. The two genes are differentially regulated at the RNA 
level in the cell cycle and in response to actinomycin D, 
cycloheximide, and PMA. 
Of particular importance, we have shown that the loss of 
expression in tumor cells does not involve physical loss of 
the genes, but is primarily at the level of transcription or 
mRNA stabilization. The evidence for transcriptional regu- 
lation is: (a) the Cx26 and Cx43 genes appear unaltered in 
restriction fragment analysis of DNA from tumor cells; (b) 
connexin mRNAs  are  faintly expressed in primary tumor 
cells but not in metastatic lines; (c) Cx26 (upper band) and 
Cx43 mRNAs are stable in the presence of acfinomycin D, 
indicating that these transcripts do not undergo rapid degra- 
dation in normal cells; and (d) Cx26 mRNA expression can 
be induced in tumor cells by treatment with PMA. 
The human Cx26 cDNA described here for the first time, 
is closely related to rat Cx26 at both the DNA and protein 
levels. The six cysteine residues found in all rat connexins 
so far described (10) are also conserved in human Cx26. In 
all, there are 15 amino acid substitutions between human and 
rat Cx26 coding regions; none are significant for structure 
as currently understood. 
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Tumor-Suppressor Genes? 
The hypothesis that gap-junctional communication contrib- 
utes to growth control and the corollary that loss of  junctions 
in tumor ceils contributes to their malignant potential, has 
been the subject of experimentation and speculation since it 
was formulated in the 1960's (I, 7, 9,  15,  17-19, 27, 29, 32, 
34). The experimental evidence, based largely on growth in- 
hibition studies with rodent fibroblasts, has been supportive 
of the hypothesis, but very indirect. Recently, transfection of 
C6 glioma cells with Cx43 (34) and of the human hepatoma 
cell line SKHepl with Cx32 (7) have provided preliminary 
evidence of decreased growth of transfectants in culture (34) 
or in nude mice (7).  In other experiments, transfection of 
weakly communicating mouse fibroblasts with Cx43 on a 
retroviral  vector  led  to  strong  overexpression  of  Cx43 
mRNA, and to enhancement of  cell-cell communication and 
decreased growth (19).  All of these studies support the hy- 
pothesis that gap-junctional communication can play a role 
in growth control, and therefore that connexins may have tu- 
mor suppressor functions. The importance of this mode of 
growth control in human cancer remains to be shown. At this 
time  genes  encoding  connexins  remain  potential  tumor- 
suppressor genes. 
We have previously divided tumor suppressor genes into 
two classes: Class I, in which the gene in itself is altered at 
the DNA level by loss or mutation; and Class II, in which 
the gene is not lost, but rather downregulated (13). On this 
scheme,  the  connexin genes described here  would be  of 
Class II (13),  as is the CAN19 gene encoding a  calcium- 
binding protein which we have recently described (14). 
Regulation of Connexin Expression 
Cx26 and Cx43 are differentially  regulated as shown by their 
cell cycle expression, and by their responses to actinomycin 
D, cycloheximide, and PMA. To examine cell cycle regula- 
tion, normal cells (70N)  were synchronized by lovastatin 
(I I). Cx43 mRNA remained at a constant steady-state level 
throughout the cell cycle, whereas the Cx26 transcripts in- 
creased in G1 and again near the end of S phase, suggesting 
their participation in  events  of (32  and M.  These results 
contrast with the increase in Cx32 mRNA and protein that 
occurs after proliferation of hepatocytes induced by partial 
hepatectomy (20). 
Gap junctions may play an important role in preparation 
for mitosis, and for junctional activity in the new daughter 
cells. The fact that the two Cx26 transcripts show different 
stabilities,  suggests  that their functions may be different. 
Further studies are required to clarify the differences in se- 
quence and regulation of the two transcripts. In addition, the 
constitutive expression of Cx43 in the cell cycle needs to be 
understood.  We  have  shown  that  either  Cx26  or  Cx43 
cDNAs will restore cell-cell communication when trans- 
fected into tumor cells (Tomasetto, C., and R. Sager, unpub- 
lished observations), showing that although both are present 
in normal epithelial cells, both are not required in the cell 
culture environment. It seems likely, therefore, that the two 
connexins have separate functions within their in vivo set- 
tings.  Further support for this view is based on sequence 
differences between the Cx26 and Cx43 proteins. Cx43 chan- 
nels are regulated posttranscriptionally by phosphorylation 
of a site not present in Cx26 protein (20, 21, 28,  33). 
The transcriptional effects of actinomycin D and cyclohex- 
imide  were  examined  to  determine  mRNA  stability  in 
NMECs, and look for induction of connexin expression in 
TMECs. Cycloheximide did not superinduce either Cx26 or 
Cx43, indicating that protein synthesis was required for their 
transcription. The relative stability of the upper Cx26 tran- 
script was seen in the presence of cycloheximide and during 
actinomycin D treatment. In contrast the lower Cx26 band 
was inhibited by both drugs. The Cx43 transcript was stable 
in the presence of either actinomycin D or cycloheximide, 
consistent with its stability in the cell cycle studies. Neither 
drug induced connexin expression in tumor cells. 
Of particular interest, we found that the tumor promoter 
PMA induced Cx26 expression in tumor cells. PMA is a well 
known inducer of protein kinase C, elevating PKC mRNA 
transiently, but leading to its downregulation within 24 h. 
Here we have found that in normal cells (81N) the Cx26 
mRNA was strongly decreased within an hour, and began to 
recover at 12-24 h, thus showing an inverse response to that 
reported for PKC expression. In the tumor cells, however, 
the Cx26 mRNA increased in the period of 3-12 h and then 
decreased. 
Thus the effects of PMA on Cx26 mRNA show a similar 
time course as PKC expression, transiently depressed in nor- 
mal ceils and elevated in tumor cells. These results suggest 
that Cx26 mRNA expression is regulated by the PKC signal- 
transduction pathway and that contrary to its inhibitory effect 
on Cx26 and Cx43 expression in normal cells, it may be 
readily inducible in tumor cells by agents that act down- 
stream of PKC. 
Concluding Remarks 
The results presented in this paper contribute to a research 
theme introduced some 25 years ago (15, 27):  a search for 
evidence that direct cell-cell communication is a homeo- 
static mechanism operating in normal cells and lost in tumor 
cells. Recent studies have put the connexin genes and pro- 
teins on a firm molecular basis, but have not yet established 
their  functional  contribution  to  the  regulation  of tumor 
growth. The fact that Cx26 expression is cell-cycle regulated 
may be important in contributing to growth control. 
This paper describes the differential transcriptional regu- 
lation of connexin expression in normal and tumor-derived 
human mammary epithelial cells. We show that the absence 
of gap junctions in tumor cells is  the result of reversible 
downregulation of Cx26 mRNA and that its re-expression 
can be induced by treatment of cells with PMA. Although 
the stimulation is transient, it suggests that a more permanent 
effect may be achieved with a different agent. The differences 
we have found in regulation and stability of Cx26 and Cx43 
transcripts provide important leads towards understanding 
the regulation of gap junctional expression. Thus, the fact 
that the connexin genes are downregulated in tumor cells 
rather than irreversibly mutated, opens new opportunities 
for research in the context of remedial chemotherapy. 
Analysis of the mechanisms of transcriptional and post- 
transcriptional regulation should contribute to developing 
ways to regulate expression exogenously, and towards under- 
standing the detailed functions of gap junctions in proliferat- 
ing and in quiescent conditions. 
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